Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 602.40
-6.50 (-1.07%)
At close: Oct 22, 2026
NSE:NEPHROPLUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, NSE:NEPHROPLUS stock has a consensus rating of "Strong Buy" and an average price target of ₹836.00. The average 1-year stock price forecast is 38.78% higher than the current stock price, while the lowest is ₹755.00 (+25.33%) and the highest is ₹1,000 (+66.00%).
Price Target: ₹836.00 (+38.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NEPHROPLUS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 2 | 2 | 2 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 4 | 5 |
Financial Forecast
Revenue This Year
12.24B
from 9.99B
Increased by 22.57%
Revenue Next Year
14.63B
from 12.24B
Increased by 19.53%
EPS This Year
15.55
from 8.10
Increased by 91.98%
EPS Next Year
20.51
from 15.55
Increased by 31.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.